Yahoo Web Search

    • Regeneron, Sanofi have positive asthma drug trial

      Market Watch· 5 days ago

      Regeneron Pharmaceuticals Inc. REGN, +3.10% and Sanofi SA (SNY.FR, SNY) on Friday said a Phase 2 proof-of-concept study of the investigational antibody REGN3500 in asthma ...

    • Here's Why AnaptysBio Shares Are Sliding Today

      The Motley Fool· 5 days ago

      Shares of AnaptysBio (NASDAQ:ANAB), a clinical-stage biotechnology company, are sliding in response to results recently posted by Regeneron (NASDAQ:REGN)...

    • Nasdaq 100 Movers: UAL, REGN

      Market Watch· 6 days ago

      Jun 20, 2019 ( via COMTEX) -- In early trading on Thursday, shares of Regeneron Pharmaceuticals topped the list of the day's best performing components of the Nasdaq 100 index ...